An Innovative Program For Optimized Evidence Generation: The Hfc Perspective On The Fda Total Product Life Cycle Advisory Program (tap)

Journal of Cardiac Failure 2026

View at publisher
Authors: Isabella Cavagna, Mona Fiuzat, Kimberly M. Ferlin, Laura Gottschalk, Andrew A. Farb, JoAnn M. Lindenfeld, Bram D. Zuckerman, Douglas Kelly
DOI: 10.1016/j.cardfail.2025.11.384
Cited by: 0

Fields of Study & Subjects

Healthcare Regulation Biomedical Ethics and Regulation Pharmaceutical Economics and Policy

Publication details

Journal / source
Journal of Cardiac Failure
Volume
32
Issue
1
Pages
326–327
Publication date
1 January 2026
Language
EN